Novartis Cosentyx® shows early synovitis reduction in patients with psoriatic arthritis in first-of-its-kind study
05 nov. 2020 01h15 HE
|
Novartis International AG
Significant reduction of synovitis (joint lining inflammation) was demonstrated with Cosentyx® at Week 12 vs. placebo, with improvements as early as Week 11 ULTIMATE is the first ever Phase IIIb...
Global Cell Based Assay & High Content Screening Market Report 2020-2024
12 oct. 2020 09h04 HE
|
Research and Markets
Dublin, Oct. 12, 2020 (GLOBE NEWSWIRE) -- The "Cell Based Assay & High Content Screening Markets Market Forecasts by Application, With Executive and Consultant Guides and including Customized...
Global Scientific Research and Development Services Global Market Forecast to Grow to From $802.2 billion in 2019 to $814.9 billion in 2020 at a CAGR of 1.6%
11 sept. 2020 05h33 HE
|
Research and Markets
Dublin, Sept. 11, 2020 (GLOBE NEWSWIRE) -- The "Scientific Research And Development Services Global Market Report 2020-30: Covid 19 Impact and Recovery" report has been added to...
Novartis Cosentyx® receives FDA approval for new indication to treat active non-radiographic axial spondyloarthritis
16 juin 2020 19h13 HE
|
Novartis International AG
FDA approval for Cosentyx® is based on the Phase III PREVENT trial, demonstrating efficacy in active non-radiographic axial spondyloarthritis (nr-axSpA), which is part of the axial spondyloarthritis...
Novartis to sponsor large clinical trial of hydroxychloroquine in hospitalized COVID-19 patients
20 avr. 2020 01h32 HE
|
Novartis International AG
Novartis has reached an agreement with the US Food and Drug Administration (FDA) to proceed with a Phase III clinical trial of hydroxychloroquine in hospitalized patients with COVID-19 disease Trial...
Brookhaven Lab Mobilizes Resources in Fight Against COVID-19
17 avr. 2020 10h29 HE
|
Brookhaven National Laboratory
UPTON, NY, April 17, 2020 (GLOBE NEWSWIRE) -- Scientists and staff at the U.S. Department of Energy's (DOE) national laboratories are marshalling their expertise, unique facilities, and other key...
Novartis and life sciences companies commit expertise and assets to the fight against COVID-19 pandemic alongside Bill & Melinda Gates Foundation
26 mars 2020 02h15 HE
|
Novartis International AG
Collaboration to address product development and scale up challenges posed by current pandemic Basel, March 26, 2020 — Today, Novartis and a consortium of life sciences companies announced an...
The Austrian Alpine state combining natural beauty with a high-tech economy
03 janv. 2020 05h00 HE
|
The New Economy
LONDON, Jan. 03, 2020 (GLOBE NEWSWIRE) -- The Austrian state of Carinthia may be best known for its crystal clear Alpine lakes and awe-inspiring mountains, but it is fast gaining in importance as a...
New Eye Tracking Glasses Bring Real-world Data to Academic Research
02 janv. 2020 09h00 HE
|
BIOPAC Systems, Inc.
GOLETA, Calif., Jan. 02, 2020 (GLOBE NEWSWIRE) -- BIOPAC Systems, Inc. announced a new eye tracking integration for researchers who conduct experiments from mobile participants in diverse locations....
Not just jewellery: The many applications of lab-grown diamonds
20 déc. 2019 04h30 HE
|
The New Economy
LONDON, Dec. 20, 2019 (GLOBE NEWSWIRE) -- Representing the height of luxury, diamonds have been used as gifts of love and respect for centuries. But diamonds have a number of practical uses too. ...